AI-Accelerated MRI: Benefits, Risks, and Clinical Reality

Dr. Linda Chu speaks with Dr. Suhny Abbara, the new Editor-in-Chief of Radiology, about his global journey in academic radiology and medical publishing. Dr. Abbara shares his vision for advancing imaging science, embracing innovation such as AI, and shaping the future of the journal to improve patient care.

Dr. Refky Nicola speaks with Dr. Sven Haller about the current clinical use of AI-accelerated MRI, exploring how these techniques improve scan speed, patient comfort, workflow efficiency, and image quality. They also examine key challenges including hallucinations, validation gaps, economic considerations, and the need for clear standards to guide safe and effective adoption. The Current Status of AI-accelerated MRI Techniques in Clinical Use. Haller et al. Radiology 2025; 317(2):e24381

This episode reviews recent evidence on microwave and radiofrequency ablation as minimally invasive treatments for primary and secondary hyperparathyroidism, highlighting efficacy, safety, and complication profiles compared with surgery. Focusing on a multicenter prospective Radiology study in older patients, the discussion shows that both ablation techniques achieve meaningful biochemical improvement with acceptable risk, particularly as alternatives for patients who may not be ideal surgical candidates. Efficacy and Safety of Microwave and Radiofrequency Ablationin the Treatment of Hyperparathyroidism in Older Individuals:A Multicenter Prospective Study. Zhang and Liu et al. Radiology 2025; 317(1):e243359. 

Dr. Lauren Kim speaks with Dr. Ritu Gill, Professor of Radiology at Columbia University, about the updated ninth edition TNM staging system for pleural mesothelioma, including the new metrics used to quantify pleural tumor in CT imaging. ARTICLE LINKS:Editorial: https://pubs.rsna.org/doi/10.1148/radiol.252343 Review: https://pubs.rsna.org/doi/10.1148/radiol.250531

*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "request-WEB:cee59b98-0957-4b41-b5d5-47fb322bf09a-2" data-testid= "conversation-turn-6" data-scroll-anchor="true" data-turn= "assistant"> Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

Dr. Sid Dogra talks with Dr. Paul Yi about the safe use of large language models and other generative AI tools in radiology, including evolving regulations, data privacy concerns, and bias. They also discuss practical steps departments can take to evaluate vendors, protect patient information, and build a long term culture of responsible AI use. Best Practices for the Safe Use of Large Language Models and Other Generative AI in Radiology. Yi et al. Radiology 2025; 316(3):e241516.

Dr. Linda Chu hosts a conversation with Dr. Chiara Bucciarelli-Ducci, Dr. Tim Leiner, and Gwenael Herigault on the latest innovations in cardiac MRI. They discuss how AI-driven workflow automation and helium-free systems are improving access, efficiency, and collaboration between radiologists and cardiologists. The episode also explores how advances in training, technology, and teamwork are enhancing care for cardiovascular patients. Sponsored by Philips Healthcare.

Dr. Linda Chu sits down with Dr. Anjum Ahmed, Chief Medical Officer at AGFA HealthCare, to explore how enterprise imaging is shaping the future of radiology through AI-driven workflows, human-centered design, and personalized patient care. Together, they discuss what "Imaging the Individual" means for radiologists today and what radiology might look like in 2030 and beyond. Sponsored by AGFA HealthCare.

Dr. Jeffrey Klein joins host Dr. Refky Nicola to reflect on his journey from aspiring internist to thoracic radiologist and longtime RSNA leader. He shares lessons from his tenure as Radiographics editor, insights on fostering community at the RSNA annual meeting, and timeless advice for the next generation of radiologists.

Our host, Dr. Celina Nahyun Jo, explores how identifying middle neck lymph node involvement can reshape clinical decision-making for nasopharyngeal carcinoma. Joined by Dr. Heejun Kang, they break down how this imaging finding could refine risk groups and potentially shift treatment intensity for certain patients. MRI-based Middle Neck Involvement in Stage N1–N2 Nasopharyngeal Carcinoma: A Marker for Risk Stratification. Qin and Jiang et al. Radiology 2025; 316(2):e243399. Middle Neck Involvement: New Layer of Risk Stratification in Nasopharyngeal Carcinoma. Jabehdar Maralani and Kang. Radiology 2025; 316(2):e252512.